Home / Financial Report / Boeing Rolls Out Fiscal Figures

Boeing Rolls Out Fiscal Figures

Boeing has released the following information about the firm’s third-quarter financial performance:

“Boeing (NYSE: BA) reported third-quarter net income of $0.8 billion, or $1.12 per share, on revenue of $17.0 billion.  The results reflect higher Commercial Airplanes volume and strong performance across the company’s core businesses.  Results in 2009 were impacted by a 787 R&D reclassification ($2.60 per share) and a 747 charge ($0.99 per share).

“The company increased its 2010 earnings per share guidance to between $3.80 and $4.00 per share and operating cash flow guidance to greater than $1.5 billion reflecting the continued strong performance in its Commercial Airplanes business.  Revenue guidance was narrowed to between $64.5 billion and $65.5 billion.

“Our results and revised outlook reflect the continued strong performance of our commercial production and services programs and the ability of our defense businesses to produce solid results in a challenging environment, ” said Jim McNerney, Boeing chairman, president and chief executive officer.  “Orders were particularly encouraging, with a multi-year production contract for 124 F/A-18 aircraft and more than 200 net commercial airplane orders booked in the quarter, increasing our backlog and demonstrating improved overall market confidence.”

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.